documents: FDA-2008-N-0326-0172
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0326-0172 | FDA | FDA-2008-N-0326 | Attachment 2 - Executive Summary and Reference List 1-16, 8-41 (Pfizer - Comment) re FDA-2008-N-0326-0165 and FDA-2008-N-0326-0346 | Supporting & Related Material | Background Material | 2008-11-04T05:00:00Z | 2008 | 11 | 2012-07-04T15:30:52Z | 0 | 0 | 09000064807940aa |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref